Shankar Siva, Radiation Oncologist at Peter MacCallum Cancer Centre, shared a post on X:

“This might just be THE DEFINITIVE meta-analysis of PSMA PET for prostate cancer recurrence.

Meta-analysis of 43 studies (n=8,119)

Sensitivity from 48% at PSA 0.2–0.5 ng/ml to >90% at PSA >2.

Congrats Declan Murphy, Marlon Perera and team European Association of Urology (EAU)!”

Shankar Siva: PSMA PET Sensitivity Surpasses 90% in Prostate Cancer Meta-Analysis

Title: The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis

Authors: Elio Mazzone, Alice Thomson, David C. Chen, Donato Cannoletta, Leonardo Quarta, Antony Pellegrino, Giorgio Gandaglia, Daniel Moon, Renu Eapen, Nathan Lawrentschuk, Francesco Montorsi, Shankar Siva, Michael S. Hofman, Arturo Chiti, Alberto Briganti, Marlon L. Perera, Declan G. Murphy

Read Full Article.

PSMA PET

Read an Article about Immunotherapy for Prostate Cancer on OncoDaily.